home
Dr reddys laboratories News
Dr reddys laboratories NEWS
market | Jan 27, 2023 3:24 PM ISTDr Reddy’s launches generic version of Durezol eye drops in US
earnings | Jan 25, 2023 5:59 PM ISTDr Reddy's net profit zooms 77 percent on strong growth in US, Russia
earnings | Jan 24, 2023 10:38 PM ISTDr Reddy's Earnings Preview: Revlimid sales may taper, Cidmus integration key
market | Jan 16, 2023 10:23 AM ISTDr Reddy’s acquires trademark rights of breast cancer drug from Pfizer India
market | Dec 16, 2022 5:47 PM ISTDr Reddy's unit Aurigene halts clinical trial for psoriasis drug
business | Nov 22, 2022 2:17 PM ISTDr Reddy's faces antitrust litigations in the US over cancer drug Revlimid generic
business | Oct 31, 2022 9:42 AM ISTAnalysts continue to bet on Dr Reddy's pinning hopes on gRevlimid
business | Oct 27, 2022 11:01 AM ISTDr Reddy's revenue seen flat but other metrics might be hit | Earnings Preview
news | Oct 3, 2022 11:26 PM ISTLIC increases its stake in Dr Reddy's Laboratories to 7.7%
business | Sept 7, 2022 9:04 PM ISTDr Reddy's to soon launch generic cancer drug Revlimid in US
business | Aug 19, 2022 12:41 PM ISTIntercept Pharmaceuticals settles Ocaliva patent litigation with Dr Reddy's
photos | Jul 29, 2022 4:20 PM ISTTata Steel, Vedanta, Yes Bank and more: Key stocks that moved the most on July 29
earnings | Jul 28, 2022 5:56 PM ISTDr Reddy's Lab net profit spikes 108% on higher income from sundries
market | Jul 8, 2022 2:49 PM ISTDr Reddy's stock recovers after falling 1% on observations from USFDA
- business | Jun 23, 2022 9:59 PM IST
Dr Reddy's says India prime target for company’s inorganic growth